In human breast, ovarian, liver and colorectal cancers, YAP1/TAZ activity positively correlates with chemoresistance, frequency of self-renewing cancer stem cells, tumour heterogeneity, histological grade and metastasis11, 12, 13. This evidence concerns the gene YAP1 and neoplasm.